Peel Hunt restated their add rating on shares of Spire Healthcare Group (LON:SPI) in a report published on Monday morning, LSE.Co.UK reports. Peel Hunt currently has a GBX 155 ($2.03) target price on the stock.
SPI has been the subject of a number of other research reports. Barclays restated an underweight rating and set a GBX 115 ($1.50) price target on shares of Spire Healthcare Group in a research note on Friday, August 9th. Liberum Capital restated a hold rating on shares of Spire Healthcare Group in a research note on Monday, August 5th. Peel Hunt upgraded shares of Spire Healthcare Group to an add rating and set a GBX 155 ($2.03) price target for the company in a research note on Monday. UBS Group restated a neutral rating and set a GBX 120 ($1.57) price target on shares of Spire Healthcare Group in a research note on Monday. Finally, Royal Bank of Canada restated an outperform rating and set a GBX 149 ($1.95) price target on shares of Spire Healthcare Group in a research note on Monday, September 9th. Two analysts have rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the company’s stock. Spire Healthcare Group currently has an average rating of Hold and a consensus price target of GBX 130.44 ($1.70).
Shares of SPI opened at GBX 115 ($1.50) on Monday. The stock has a market cap of $461.24 million and a price-to-earnings ratio of 41.07. The company has a quick ratio of 0.95, a current ratio of 1.44 and a debt-to-equity ratio of 48.52. Spire Healthcare Group has a 12 month low of GBX 95.25 ($1.24) and a 12 month high of GBX 176 ($2.30). The company has a 50-day moving average price of GBX 106.29 and a two-hundred day moving average price of GBX 121.25.
Spire Healthcare Group Company Profile
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Further Reading: What is an overbought condition?
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.